Article Details

Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche's Xolair for hives condition ...

Retrieved on: 2022-02-18 15:40:41

Tags for this article:

Click the tags to see associated articles and topics

Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche's Xolair for hives condition .... View article details on hiswai:

Excerpt

... tested Dupixent in those who haven't had success with the lone therapy approved for the condition—Novartis and Roche's Xolair.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up